Jensen Christer A, Abramova Tatiana, Frengen Jomar, Lund Jo-Åsmund
Department of Oncology, Ålesund Hospital, Ålesund, Norway.
Clinic of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
J Appl Clin Med Phys. 2017 Sep;18(5):117-123. doi: 10.1002/acm2.12137. Epub 2017 Jul 29.
Deep inspiration breath hold (DIBH) in left-sided breast cancer radiotherapy is a technique to reduce cardiac and pulmonary doses while maintaining target coverage. This study aims at evaluating an in-house developed DIBH system. Free-breathing (FB) and DIBH plans were generated for 22 left-sided localized breast cancer patients who had radiation therapy (RT) after breast-conserving surgery. All patients were treated utilizing an in-house laser distance measuring system. 50 Gy was prescribed, and parameters of interest were target coverage, left anterior descending coronary artery, (LAD) and heart doses. Portal images were acquired and the reproducibility and stability of DIBH treatment were compared to FB. The comparing result shows there is a significant reduction in all LAD and heart dose statistics for DIBH compared to FB plans without compromising the target coverage. The maximum LAD dose was reduced from 43.7 Gy to 29.0 Gy and the volume of the heart receiving >25 Gy was reduced from 3.3% to 1.0% using the in-house system, both statistically significant. The in-house system gave a reproducible and stable DIBH treatment where the systematic error ∑, and random error σ, were less than 2.2 mm in all directions, but were not significantly better than at FB. The system was well tolerated and all patients completed their treatment sessions with DIBH.
左侧乳腺癌放疗中的深吸气屏气(DIBH)技术是一种在维持靶区覆盖的同时降低心脏和肺部剂量的方法。本研究旨在评估一种自主研发的DIBH系统。为22例保乳手术后接受放射治疗(RT)的左侧局限性乳腺癌患者制定了自由呼吸(FB)和DIBH计划。所有患者均使用自主研发的激光测距系统进行治疗。处方剂量为50 Gy,感兴趣的参数包括靶区覆盖、左前降支冠状动脉(LAD)和心脏剂量。采集了射野图像,并将DIBH治疗的重复性和稳定性与FB进行了比较。比较结果显示,与FB计划相比,DIBH的所有LAD和心脏剂量统计数据均显著降低,且不影响靶区覆盖。使用自主研发的系统,LAD最大剂量从43.7 Gy降至29.0 Gy,接受>25 Gy照射的心脏体积从3.3%降至1.0%,两者均具有统计学意义。自主研发的系统提供了可重复且稳定的DIBH治疗,其在各个方向上的系统误差∑和随机误差σ均小于2.2 mm,但并不比FB显著更好。该系统耐受性良好,所有患者均完成了DIBH治疗疗程。